The short answer
SEER reports a 13.7% five-year relative survival rate for pancreatic cancer overall, one of the lowest of any cancer type, mainly because it is usually found late. Localized pancreatic cancer is 43.6%; distant (metastatic) disease is only 3.4%. Whether the tumor can be surgically removed is central to outlook.
A survival statistic describes a large group diagnosed years ago — not a prediction for any one person.
For pancreatic cancer, the five-year relative survival rate for everyone combined, diagnosed 2016–2022, was 13.7%.
Stage at diagnosis makes a large difference: localized disease is 43.6% versus 3.4% for distant (metastatic) disease.
Whether the tumor can be surgically removed (resectability) is central to pancreatic cancer treatment and outlook.
Choose how you want to understand this
The full explanation.
Before you look at the numbers
Three things are true about the numbers below. Please read all three before you look at a single pancreatic cancer percentage.
First, a "5-year relative survival rate" for pancreatic cancer describes a large group of people. Those people were diagnosed with pancreatic cancer years ago. It is not a prediction about you. Everyone's pancreatic cancer, body, and treatment plan are different.
Second, this data lags behind today's care. These figures reflect people diagnosed with pancreatic cancer between 2016 and 2022. Pancreatic cancer treatment has continued to change since then, including newer chemotherapy combinations. So pancreatic cancer treatment today may already work better than these numbers suggest.
Third, an all-stages pancreatic cancer number blends two very different groups. It mixes people whose pancreatic cancer was found early. It also counts people whose pancreatic cancer had already spread. For pancreatic cancer, the stage-specific numbers below beat one blended average. And "5-year" is just a measuring window, not a pancreatic cancer milestone. It is not a life expectancy for anyone with pancreatic cancer. It is not a deadline either.
The SEER numbers for pancreatic cancer
SEER's most recent report covers people diagnosed with pancreatic cancer between 2016 and 2022. Across every stage combined, the five-year relative survival rate was 13.7%. That is one of the lowest of any major cancer type. It mostly reflects how often pancreatic cancer is found after it has already spread. It does not reflect how treatable early pancreatic cancer can be.
Only about 15% of pancreatic cancers are found at the localized stage. About half are already distant at diagnosis.
| Stage at diagnosis | 5-year relative survival |
|---|---|
| Localized — confined to the pancreas | 43.6% |
| Regional — spread to nearby lymph nodes | 17.0% |
| Distant — spread to other parts of the body | 3.4% |
| Unknown/unstaged | 12.5% |
What "relative survival" actually means
Relative survival compares two groups. One group has pancreatic cancer. The other group is the same age and sex, but has no pancreatic cancer. Say the rate is 100%. That would mean the pancreatic cancer group was as likely to reach 5 years as the other. It is not the share of people who are free of pancreatic cancer. It is not the share of people who die from pancreatic cancer itself.
For pancreatic cancer, one of the most important factors in outlook is whether surgery can remove the entire tumor. Doctors call that resectability. It often tells you more than the localized, regional and distant categories alone. Pancreatic cancer also rarely causes early symptoms. That is a major reason it is often found later than other cancers.
What actually changes your outlook
A statistic describes a group. Your outlook depends on things specific to you.
- Stage — how far the pancreatic cancer has spread, as shown in the table above.
- Grade — how odd the pancreatic cancer cells look, and how fast they tend to grow.
- Resectability — whether surgery can remove the tumor completely, based on imaging.
- CA 19-9 level — a blood marker sometimes used to help track the cancer.
- How your pancreatic cancer responds — early scans and labs often say more than the first numbers.
- Your overall health — other health problems, age, and fitness shape pancreatic cancer treatment and recovery.
- Access to care — a quick pancreatic cancer diagnosis, specialist care, and finishing treatment all matter.
Questions for your care team
- Which SEER stage describes my pancreatic cancer, and what is its five-year number?
- Which biomarkers or molecular tests matter in pancreatic cancer, and were they run on my sample?
- How do my age and overall health change these pancreatic cancer statistics for me?
- Are there newer pancreatic cancer treatments available now that this data doesn't reflect yet?
- Beyond the general pancreatic cancer statistics, what does my team expect in my case?
- Where can I find support for how it feels to hear these pancreatic cancer numbers?
- Is my pancreatic cancer considered resectable, borderline resectable, or unresectable, and why?
If these numbers are hard to sit with
Pancreatic cancer numbers can leave you scared, numb, or overwhelmed. That is normal. It does not mean you are handling a pancreatic cancer diagnosis the wrong way. Many people take these pancreatic cancer numbers in slowly, or with someone in the room. Others skip the numbers until they feel ready. Cancer Anxiety and Uncertainty covers the fear these pancreatic cancer numbers can stir up. It is also worth telling your pancreatic cancer team how much detail you want, and when.
Sources
Words to know
Tap any term to see what it means.
Common questions
What does 13.7% five-year relative survival mean for pancreatic cancer?
It means that, on average, people diagnosed with pancreatic cancer between 2016 and 2022 were about 13.7% as likely to be alive 5 years later as people of the same age and sex without pancreatic cancer. It blends every stage together, from early to advanced.
Why is the stage-specific number so different from the overall number?
The overall number blends people found early, when pancreatic cancer is most treatable, with people found later. Stage makes a large difference — see the table above. Localized pancreatic cancer usually has a much higher five-year relative survival than distant (metastatic) disease.
Does this number predict what will happen to me?
No. This is a statistic about a large group of people, not a prediction about you. Your age, overall health, tumor biology, and how your pancreatic cancer responds to treatment all shape your individual outlook in ways a group statistic cannot capture.
Is this the most current data available?
It is the most recent data SEER has published, but it still reflects people diagnosed in 2016–2022. Treatments keep changing, so people diagnosed today may do better than these numbers suggest.
Why is pancreatic cancer so often found late?
The pancreas sits deep in the abdomen, and early pancreatic cancer usually causes no symptoms, or only vague ones like mild discomfort or appetite changes. By the time symptoms like jaundice or weight loss appear, the cancer has often already spread. This is why about half of pancreatic cancers are diagnosed at the distant stage.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-08-17Next planned review: 2027-08-03
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share